According to the company, the appointments are part of its strategy to strengthen its sales hierarchy, improve operational efficiency, and expand market reach across regions. The move is also expected to support growth in export markets alongside domestic expansion.
Shelter Pharma is a pharmaceutical manufacturing company, specializing in herbal remedies for both human and veterinary healthcare.
The company's standalone net profit jumped 27.12% to Rs 4.50 crore on 38.36% rise in net sales to Rs 33.29 crore in the half year ended September 2025 over the half year ended September 2024.
FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com
BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737
ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)
© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.
Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)